prostate cancer

[Prostate Cancer and Prostatic Diseases] The authors conducted a systematic review and meta-analysis to determine the incidence of late genitourinary toxicity relying on radiation therapy oncology group and common terminology criteria for adverse events grade as well as the incidence of specific genitourinary toxicity.

[Cancer Cell International] Expression levels of miR-630 can be used as markers for prediction of cancer course. Moreover, miR-630 can influence response to chemoradiotherapy.

[Communications Biology] Researchers observed that several ovarian tumor members displayed genomic amplification in prostate cancer, among which ovarian tumor deubiquitinase 6A (OTUD6A) amplified in the top around 15–20%.

[Oncogenesis] Scientists showed that miR-32 promoted MYC-induced prostate adenocarcinoma and identified PDK4 as a prostate cancer-relevant metabolic target of miR-32-3p.

[Scientific Reports] The authors irradiated prostate cancer cells either with a single dose of 10 Gy x-ray or a multifractionated regimen with 10 fractions of 1 Gy.

[andrology] Circ_0076305 served as a novel oncogene prostate cancer progression through regulation of microRNA-411-5p (miR-411-5p)/phosphoglycerate kinase 1 (PGK1) axis.